2022年3月2日 · Rice University bioengineering graduate student Amanda Nash is creating cell-encapsulation technologies to treat cancer. Nash and colleagues created the technology with an eye toward rapid approval for human clinical trials, using only components that have previously proven safe for use in humans.

2022年8月3日 · Rice University bioengineers Amanda Nash (left) and Omid Veiseh with vials of bead-like “drug factories” they created to treat cancer. Federal regulators have approved the first human clinical trial of the pinhead-sized implants, which produce natural compounds that program the immune system to attack tumors.

2024年9月20日 · Study authors Amanda Nash and Omid Veiseh with their “drug factory” beads. Nash, Veiseh and colleagues showed the implants could eradicate ovarian and colorectal cancer in mice in as little as six days.

2020年8月10日 · Amanda Nash, a second-year Ph.D. student in bioengineering at Rice University, has been awarded a 2020 Graduate Research Fellowship (GRF) from the National Science Foundation. Nash is one of 21 students in the George R. Brown School of Engineering who received one this year.

2022年8月22日 · “From the beginning, our objective was to develop a platform therapy that can be used for multiple different types of immune system disorders or different types of cancers,” said Rice graduate student Amanda Nash, who spent several years developing the implant technology with study co-lead author Samira Aghlara-Fotovat, a fellow student in ...

2022年4月7日 · IL-2, a type of molecule known as a cytokine, “is a known potent activator of T cells—the fighter cells of the immune system—and boosts their normal ability to eliminate cancer cells,” said Amanda Nash, the study’s lead researcher and a graduate student in Dr. Veiseh’s lab.

Dr. Omid Veiseh, Ph.D. is a Professor in the Department of Bioengineering and Director of the Biotech Launch Pad at Rice University, where he leads a research program aimed at engineering next-generation treatments for a wide range of human diseases by leveraging the latest techniques in synthetic biology, immunoengineering, and materials scienc...

The treatment and test results were recently published in a Science Advances study co-authored by Omid Veiseh, graduate student Amanda Nash, and colleagues from Rice, the University of Texas MD Anderson Cancer Center, the University of Virginia and others.

I am a PhD student in the department of Bioengineering at Rice University. My work is focused on developing hydrogel-based drug delivery systems for human diseases. I graduated from UH with a bachelor’s in biomedical engineering in May 2018.